Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.

BMC Cancer · 2022 · PMC9175328 · PMID 35672745

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

failed to reach statistical significancep = 0.068so close (0.05 < p ≤ 0.1)

Interestingly, anemia/Hb improvement post-RT for those with baseline anemia failed to reach statistical significance and was marginally associated with improved OS ( p = 0.068) (Fig. 3 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.